EGR2 Antikörper (AA 200-300)
Kurzübersicht für EGR2 Antikörper (AA 200-300) (ABIN7266888)
Target
Alle EGR2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 200-300
-
Verwendungszweck
- EGR2 Rabbit pAb
-
Sequenz
- LAYPPPPSYP SPKPATDPGL FPMIPDYPGF FPSQCQRDLH GTAGPDRKPF PCPLDTLRVP PPLTPLSTIR NFTLGGPSAG VTGPGASGGS EGPRLPGSSS A
-
Kreuzreaktivität
- Maus
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- A synthetic peptide corresponding to a sequence within amino acids 200-300 of human EGR2 (NP_000390.2).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:500 - 1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- EGR2 (Early Growth Response 2 (EGR2))
-
Andere Bezeichnung
- EGR2
-
Hintergrund
- The protein encoded by this gene is a transcription factor with three tandem C2H2-type zinc fingers. Defects in this gene are associated with Charcot-Marie-Tooth disease type 1D (CMT1D), Charcot-Marie-Tooth disease type 4E (CMT4E), and with Dejerine-Sottas syndrome (DSS). Multiple transcript variants encoding two different isoforms have been found for this gene.,EGR2,AT591,CMT1D,CMT4E,KROX20,Epigenetics & Nuclear Signaling,Transcription Factors,Neuroscience,Neurodegenerative Diseases,EGR2
-
Molekulargewicht
- 44kDa/50kDa
-
Gen-ID
- 1959
-
UniProt
- P11161
Target
-